Charles River Laboratories International, Inc. today announced continued momentum in its digital pathology platform, delivering an end-to-end, AI-enabled workflow that significantly accelerates study ...
The landscape for video training data and multimodal foundation models in 2026 is defined by a shift from quantity to highly ...
Ligand-based drug design combines AI and QSAR modeling to prioritize drug candidates, minimizing preclinical failures and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results